BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22066163)

  • 1. [EQUALIS expert group for coagulation. Functional method for the first choice diagnostics of hereditary antithrombin deficiency].
    Strandberg K
    Lakartidningen; 2011 Aug 24-30; 108(34):1552. PubMed ID: 22066163
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombin.
    Hepner M; Karlaftis V
    Methods Mol Biol; 2013; 992():355-64. PubMed ID: 23546728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory diagnosis of hereditary thrombophilia.
    Michiels JJ; Hamulyák K
    Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary antithrombin deficiency--rare, but serious. Great risk of venous thromboembolism].
    Bremme K; Petrini P; Sallamba M; Tengborn L
    Lakartidningen; 2011 Aug 24-30; 108(34):1564-8. PubMed ID: 22066166
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of Hereditary Thrombophilia: Performance of Antithrombin (AT) Testing.
    Gausman JN; Marlar RA
    Methods Mol Biol; 2017; 1646():161-167. PubMed ID: 28804827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative bridging with fondaparinux in a woman with antithrombin deficiency.
    Bauersachs R; Alban S
    Thromb Haemost; 2007 Mar; 97(3):498-9. PubMed ID: 17334522
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis of thrombophilia]].
    Kemkes-Matthes B
    Zentralbl Chir; 2001 Jun; 126(6):433-7. PubMed ID: 11446062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical multicenter evaluation of a new FXa-based Antithrombin assay.
    Merz M; Böhm-Weigert M; Braun S; Cooper PC; Fischer R; Hickey K; Steffan A; Kemkes-Matthes B; Kitchen S
    Int J Lab Hematol; 2011 Oct; 33(5):498-506. PubMed ID: 21535419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heparin cofactor II (HCII)].
    Yoshikawa T; Hayashi T; Suzuki K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():667-70. PubMed ID: 15658419
    [No Abstract]   [Full Text] [Related]  

  • 13. [Etiological analysis of thrombophilia].
    Tsuda H; Iida H; Nakahara M; Hattori S; Tanabe S; Fujise M; Kinoshita S; Hamasaki N
    Rinsho Byori; 1997 Nov; 45(11):1025-30. PubMed ID: 9396341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
    Akai Y; Shiga S; Tohyama K; Shimatsu A; Ichiyama S
    Rinsho Byori; 2000 Sep; 48(9):867-71. PubMed ID: 11051806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparin cofactor II and thrombophilic conditions].
    Hudecek J; Hal'áková E; Ivanková J; Kubisz P
    Vnitr Lek; 1997 May; 43(5):317-9. PubMed ID: 9601856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of hypercoagulable states].
    Páramo JA; López Y; Muñoz C; Rodríguez-Calvillo M; Panizo C
    Sangre (Barc); 1997 Dec; 42(6):493-502. PubMed ID: 9490914
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative performance of three anti-factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous, unfractionated heparin.
    Lehman CM; Rettmann JA; Wilson LW; Markewitz BA
    Am J Clin Pathol; 2006 Sep; 126(3):416-21. PubMed ID: 16880140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin cofactor II deficiency.
    Tollefsen DM
    Arch Pathol Lab Med; 2002 Nov; 126(11):1394-400. PubMed ID: 12421148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital disorders of hemostasis with thrombophilia].
    Egbring R; Seitz R
    Internist (Berl); 1989 Sep; 30(9):577-86. PubMed ID: 2509393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.